BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2965015)

  • 21. Inhibition of chemically induced mammary carcinogenesis in rats by long-term exposure to butylated hydroxytoluene (BHT): interrelations among BHT concentration, carcinogen dose, and diet.
    Cohen LA; Choi K; Numoto S; Reddy M; Berke B; Weisburger JH
    J Natl Cancer Inst; 1986 Apr; 76(4):721-30. PubMed ID: 3083149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
    McCormick DL; Moon RC
    Carcinogenesis; 1986 Feb; 7(2):193-6. PubMed ID: 2936526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-initiation treatment of rats with indole-3-carbinol or beta-naphthoflavone does not suppress 7, 12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis.
    Malejka-Giganti D; Niehans GA; Reichert MA; Bliss RL
    Cancer Lett; 2000 Nov; 160(2):209-18. PubMed ID: 11053651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
    Abou-Issa H; Webb TE; Minton JP; Moeschberger M
    J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
    Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM
    Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S; Mevissen M; Löscher W
    Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticarcinogenic effect of retinoids on 7,12-dimethylbenz(a)anthracene-induced mammary tumor induction, and its relationship to cyclic AMP-dependent protein kinase.
    Abou-Issa H; Duruibe VA
    Biochem Biophys Res Commun; 1986 Feb; 135(1):116-23. PubMed ID: 3006676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
    VanderPloeg LC; Wolfrom DM; Welsch CW
    Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory action of Piper betle on the initiation of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in rats.
    Rao AR; Sinha A; Selvan RS
    Cancer Lett; 1985 Mar; 26(2):207-14. PubMed ID: 3919938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of caffeine and/or coffee consumption on the initiation and promotion phases of 7,12-dimethylbenz(a)anthracene-induced rat mammary gland tumorigenesis.
    Welsch CW; DeHoog JV; O'Connor DH
    Cancer Res; 1988 Apr; 48(8):2068-73. PubMed ID: 3127044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human chorionic gonadotropin and rat mammary cancer prevention.
    Russo IH; Koszalka M; Russo J
    J Natl Cancer Inst; 1990 Aug; 82(15):1286-9. PubMed ID: 2115592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis.
    Kocdor H; Kocdor MA; Canda T; Gurel D; Cehreli R; Yilmaz O; Alakavuklar M; Guner G
    Clin Transl Oncol; 2009 Apr; 11(4):243-9. PubMed ID: 19380302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cholesterol and 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis.
    Klurfeld DM; Kritchevsky D
    Cancer Lett; 1981 Dec; 14(3):273-8. PubMed ID: 6800640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of rat mammary carcinogenesis by indomethacin.
    McCormick DL; Madigan MJ; Moon RC
    Cancer Res; 1985 Apr; 45(4):1803-8. PubMed ID: 3919946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats.
    Pereira MA; Grubbs CJ; Barnes LH; Li H; Olson GR; Eto I; Juliana M; Whitaker LM; Kelloff GJ; Steele VE; Lubet RA
    Carcinogenesis; 1996 Jun; 17(6):1305-11. PubMed ID: 8681447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of caffeine consumption on 7,12-dimethylbenz(a)anthracene-induced mammary gland tumorigenesis in female rats fed a chemically defined diet containing standard and high levels of unsaturated fat.
    Welsch CW; DeHoog JV
    Cancer Res; 1988 Apr; 48(8):2074-7. PubMed ID: 3127045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats.
    Tanaka H; Hirose M; Kawabe M; Sano M; Takesada Y; Hagiwara A; Shirai T
    Cancer Lett; 1997 Jun; 116(1):47-52. PubMed ID: 9177457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model.
    Abou-Issa H; Curley RW; Panigot MJ; Tanagho SN; Sidhu BS; Alshafie GA
    Anticancer Res; 1997; 17(5A):3335-9. PubMed ID: 9413168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
    Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
    Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
    Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ
    Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.